Five-year follow-up after live donor nephrectomy – cross-sectional and longitudi

[Clark]

http://onlinelibrary.wiley.com/doi/10.1111/tri.12872/abstract?wol1URL=/doi/10.1111/tri.12872/abstract&campaign=wolacceptedarticle&regionCode=US-MA&identityKey=a5109188-bc4b-4411-a341-f25d0601fa74

Five-year follow-up after live donor nephrectomy – cross-sectional and longitudinal analysis of a prospective cohort within the era of extended donor eligibility criteria
Authors
      Shiromani Janki, et al.,
      First published: 14 November 2016
      DOI: 10.1111/tri.12872
Summary
To establish the outcome of live kidney donors 5 years after donation, we investigated the risk for progressive renal function decline and quality of life (QoL). Data on estimated glomerular filtration rate (eGFR), creatinine, hypertension, QoL and survival were assessed in a prospective cohort of 190 donors, who donated between 2008 and 2010. Data were available for >90%. The mean age predonation was 52.8 ± 11.5 years, 30 donors having pre-existent hypertension. The mean follow-up was 5.1 ± 0.9 years. Eight donors had died due to non-donation-related causes. After 5 years, the mean eGFR was 60.2 (95% CI 58.7–62.7) ml/min/1.73 m2, with a median serum creatinine of 105.1 (95% CI 102.5–107. μmol/l. eGFR decreased to 33.6% and was longitudinally lower among men than women and declining with age (P < 0.001), without any association on QoL. Donors with pre-existent and new-onset hypertension demonstrated no progressive decline of renal function overtime compared to nonhypertensives. No donors were found with proteinuria, microalbuminuria or at risk for end-stage renal disease. After an initial decline postdonation, renal function remained unchanged overtime. Men and ageing seem to affect renal function overtime, while decreased renal function did not affect QoL. These data support further stimulation of living kidney donation programmes as seen from the perspective of donor safety.